# Neostigmine Methylsulfate

NDC: 72572-462
Generic name: Neostigmine Methylsulfate
Labeler / Manufacturer: Civica, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20200416

FDA application: ANDA207042

## Active ingredients

- NEOSTIGMINE METHYLSULFATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72572-462"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72572-462
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=454d54dc-b803-4519-81e8-ac7d21e6aae1